Dow Up 0.12% Nasdaq Up 1.35%

Avanir Pharmaceuticals, Inc. (AVNR)

-NMS
11.68 0.76(6.96%) Oct 20, 4:00PM EDT
Prev Close:10.92
Open:10.86
Bid:11.70 x 100
Ask:12.50 x 100
1y Target Est:17.80
Beta:0
Earnings Date:Dec 8 - Dec 12 (Est.)
Day's Range:10.81 - 11.79
52wk Range:2.62 - 13.09
Volume:3,473,141
Avg Vol (3m):5,410,830
Market Cap:2.01B
P/E (ttm):N/A
EPS (ttm):-0.46
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for AVNR

Comparison

Symbol% ChgMkt Cap
AVNRUp 6.96%2.01B
BMY83.82B
LLY67.62B
GSK104.75B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):18.05
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Sep-14) :-0.29
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):-0.69

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Avanir Pharmaceuticals, Inc., together with its subsidiaries, is engaged in acquiring, developing, and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback